AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Glimibose-M2 Tablet PR

Prescription Icon
Prescription Required

Marketer

B.J.Healthcare

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimibose-M2 Tablet PR

Combiflor-D, a dual-action antidiabetic medication, manages type 2 diabetes in adults. This formulation combines two agents to regulate blood glucose. Always take Combiflor-D with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your glucose readings. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to complications like nephropathy, retinopathy, neuropathy, and limb loss. Remember, Combiflor-D complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect, manifesting as sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential. Alcohol increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalgia, and upper respiratory infections. Weight gain is also possible. Combiflor-D is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiac disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to track blood cell counts and liver function.

Uses of Glimibose-M2 Tablet PR

Managing Type 2 Diabetes

Major Benefits of Glimibose-M2 Tablet PR:

Follow your physician's instructions or consult the product label for dosage guidance. Administer Glimibose-M2 Tablet PR with meals.

Common Side effects of Glimibose-M2 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimibose-M2 Tablet PR:

Follow your physician's instructions or consult the product label for usage guidance. Administer Glimibose-M2 Tablet PR with meals.

How Glimibose-M2 Tablet PR works:

Glimibose-M2 Tablet PR combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Glimibose-M2 Tablet PR ingestion poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimibose-M2 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

The use of Glimibose-M2 Tablet PR while breastfeeding is contraindicated due to potential infant toxicity. Evidence indicates a risk of harm to the nursing infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimibose-M2 Tablet PR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimibose-M2 Tablet PR cautiously, potentially requiring dosage modification. Consultation with a physician is advisable. For those with mild to moderate liver disease, a low initial dose is typically prescribed; its use is contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Glimibose-M2 Tablet PR :

For a missed Glimibose-M2 Tablet PR dose, take it promptly unless your next dose is imminent. In that case, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glimibose-M2 Tablet PR

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Glimibose-M2 Tablet PR

Maintain this medication within its original, sealed container. Follow the storage guidelines provided on the packaging. Discard any remaining medication. Prevent access by children, pets, and others.
Lactic acidosis, a serious medical condition resulting from excessive blood lactic acid, is a potential adverse effect of Glimibose-M2 Tablet PR. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful complication is particularly risky for individuals with impaired kidney function, the elderly, or those who consume significant quantities of alcohol. Manifestations can include muscular discomfort or weakness, vertigo, fatigue, peripheral coldness, respiratory distress, nausea, emesis, abdominal pain, and bradycardia. Should these symptoms arise, discontinue Glimibose-M2 Tablet PR and seek immediate medical attention.
Glimibose-M2 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication enhances glycemic control when used concurrently with a healthy diet and regular physical activity. Glimepiride functions by stimulating pancreatic insulin secretion, while metformin reduces hepatic glucose production and improves insulin responsiveness. This dual-agent therapy is unsuitable for type 1 diabetes mellitus.
Glimibose-M2 Tablet PR may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use can result in vitamin B12 deficiency.
Prolonged Glimibose-M2 Tablet PR administration can indeed lead to Vitamin B12 deficiency due to impaired intestinal Vitamin B12 absorption. This deficiency, if left unaddressed, may manifest as anemia, neurological complications including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and ataxia. Preventive measures, according to some studies, include annual supplemental Vitamin B12 intake.
Indeed, Glimibose-M2 Tablet PR can induce hypoglycemia (low blood glucose). Manifestations of low blood sugar encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of unease or tremor. These symptoms are more likely if meals are skipped or delayed, alcohol is consumed, excessive exercise is undertaken, or concomitant antidiabetic medications are used. Consequently, consistent blood glucose monitoring is crucial. Carrying a readily available source of glucose, such as glucose tablets, honey, or fruit juice, is advisable.
Consuming alcohol concurrently with Glimibose-M2 Tablet PR is inadvisable due to the risk of significantly reduced blood glucose, potentially resulting in hypoglycemia. Furthermore, this combination elevates the likelihood of lactic acidosis.
Glimibose-M2 Tablet PR
57
MRP 70
18% off